research
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients
- Publication date
- 1 January 2016
- Publisher
- 'Elsevier BV'